What is HIV-Associated Facial Lipoatrophy?
Facial Lipoatrophy is a frustrating reality for many HIV-positive people. Characterized by the loss of fat underneath the skin, Facial Lipoatrophy is not life-threatening, but it is one of the most stigmatizing and troubling complications of HIV treatment. Numerous studies have shown that Facial Lipoatrophy can have detrimental effects on an affected person's self-confidence and quality of life.
Facial Lipoatrophy is a potential problem in the approximately one million people in the United States who are HIV-positive. Facial Lipoatrophy can result in sunken cheeks, hollow eyes, and indentations. Although persons affected by facial lipoatrophy often have well-controlled HIV disease and are otherwise healthy, the effects of HIV facial lipoatrophy may suggest otherwise, resulting in stigmatization and psychological trauma. Radiesse® dermal filler is a safe, next generation dermal filler for correction of the signs Facial Lipoatrophy that provides both immediate and long-lasting results.
What is RADIESSE dermal filler?
What Causes HIV-Associated Facial Lipoatrophy?
Although the causes are not completely clear, they may include:
- long-term HIV infection
- elevated lipid profiles
- damage to cell mitochondria
- long-term use of some antiretroviral medications
Facial Lipoatrophy can negatively affect a number of different areas of a person's life, including:
- self-confidence
- desire to participate in social activities
- sex drive
- emotional well-being
- willingness or ability to adhere to treatment
- commitment to staying on treatment
Facial Lipoatrophy Treatment Can Help
Facial Lipoatrophy can contribute to depression or a patient’s termination of treatment. RADIESSE dermal filler can correct the signs of HIV-Associated Facial Lipoatrophy and can provide both immediate and long-lasting results. Check out our Before-and-After Gallery to see what RADIESSE filler has done for real patients.
Want to learn more? Find out how RADIESSE Lipoatrophy treatment works.